These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 30648776

  • 1. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 2. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y, Ma H, Zhao C, Liu T, Yan D, Jou D, Li H, Zhang C, Lü J, Li C, Lin J, Li S, Lin L.
    Oncotarget; 2017 May 16; 8(20):33683-33693. PubMed ID: 28430601
    [Abstract] [Full Text] [Related]

  • 3. Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
    Xiao H, Bid HK, Chen X, Wu X, Wei J, Bian Y, Zhao C, Li H, Li C, Lin J.
    PLoS One; 2017 May 16; 12(7):e0180297. PubMed ID: 28672024
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma.
    Liu T, Ma H, Shi W, Duan J, Wang Y, Zhang C, Li C, Lin J, Li S, Lv J, Lin L.
    Int J Oncol; 2017 Aug 16; 51(2):555-562. PubMed ID: 28714512
    [Abstract] [Full Text] [Related]

  • 5. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J, Chen X, Fu S, Zhang R, Pan L, Cao Y, Wu X, Xiao H, Lin HJ, Lo HW, Zhang Y, Lin J.
    Breast Cancer Res Treat; 2019 Jun 16; 175(3):553-566. PubMed ID: 30852762
    [Abstract] [Full Text] [Related]

  • 6. Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.
    Wei J, Ma L, Lai YH, Zhang R, Li H, Li C, Lin J.
    J Exp Clin Cancer Res; 2019 Feb 08; 38(1):63. PubMed ID: 30736824
    [Abstract] [Full Text] [Related]

  • 7. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.
    Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719
    [Abstract] [Full Text] [Related]

  • 8. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

  • 9. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S, Gao Y, Huang X, Wang X.
    Int J Oncol; 2014 Apr 24; 44(4):1259-67. PubMed ID: 24535538
    [Abstract] [Full Text] [Related]

  • 10. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1247-1254. PubMed ID: 27091428
    [Abstract] [Full Text] [Related]

  • 11. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S, Tian J, Zhang H, Zhou S, Wang X, Zhang L, Yang J, Zhang Z, Ji Z.
    Apoptosis; 2018 Jun 13; 23(5-6):356-374. PubMed ID: 29777330
    [Abstract] [Full Text] [Related]

  • 12. Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
    Luo P, Wang Y, Zhao C, Guo J, Shi W, Ma H, Liu T, Yan D, Huo S, Wang M, Li C, Lin J, Li S, Lv J, Zhang C, Lin L.
    Eur J Pharmacol; 2021 Feb 15; 893():173822. PubMed ID: 33347820
    [Abstract] [Full Text] [Related]

  • 13. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
    Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676
    [Abstract] [Full Text] [Related]

  • 14. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.
    Br J Pharmacol; 2013 Oct 13; 170(4):807-21. PubMed ID: 23848338
    [Abstract] [Full Text] [Related]

  • 15. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB, Fan HJ, Wu YT, Xie LP, Bi YM, Xu HL, Chen HM, Li J, Liu B, Zhou YC.
    J Ethnopharmacol; 2019 Mar 25; 232():62-72. PubMed ID: 30553869
    [Abstract] [Full Text] [Related]

  • 16. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Hu Z, Luo D, Wang D, Ma L, Zhao Y, Li L.
    Cell Physiol Biochem; 2017 Mar 25; 43(6):2379-2390. PubMed ID: 29073625
    [Abstract] [Full Text] [Related]

  • 17. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J.
    Oncol Rep; 2013 Sep 25; 30(3):1309-14. PubMed ID: 23828071
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I, Seel NN, Hering NA, Hartmann L, Liu V, Camaj P, Müller MH, Lee LD, Bruns CJ, Kreis ME, Seeliger H.
    Cell Oncol (Dordr); 2021 Feb 25; 44(1):167-177. PubMed ID: 32940862
    [Abstract] [Full Text] [Related]

  • 19. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
    Wu X, Cao Y, Xiao H, Li C, Lin J.
    Mol Cancer Ther; 2016 Nov 25; 15(11):2609-2619. PubMed ID: 27535971
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
    Park SA, Kim LK, Park HM, Kim HJ, Heo TH.
    Oncol Rep; 2022 Mar 25; 47(3):. PubMed ID: 35029286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.